EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular targets of vortioxetine mediating glioblastoma suppression revealed by gene and protein network analyses and molecular docking simulations

Chuanjun Zhuo iD, Chao Li, Qiuyu Zhang, Lei Yang, Ying Zhang, Ximing Chen, Xiaoyan Ma, Ranli Li, Lina Wang, Hongjun Tian

International Journal of Neuropsychopharmacology · 2025

DOI: 10.1093/ijnp/pyaf029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2025. Verfasst von Chuanjun Zhuo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tian…. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Vortioxetine, Glioblastoma, Protein Interaction Maps. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vortioxetine is a serotonin reuptake inhibitor and serotonin receptor modulator used for the treatment of major depressive disorder, but recent studies have also reported anticancer effects in models of glioblastoma. Given the well-established benefits of drug repositioning, we examined the pharmacological mechanism for these anticancer actions using bioinformatics and molecular docking.

Methods

Putative molecular targets for vortioxetine were identified by searching DrugBank, GeneCards, SwissTargetPrediction, Comparative Toxicogenomics Database, and SuperPred databases, while glioblastoma-related proteins were identified using GeneCards, Online Mendelian Inheritance in Man; , and Therapeutic Target Database . A protein–protein interaction (PPI) network was constructed from vortioxetine targets also involved in glioblastoma to identify core (hub) targets, which were then characterized by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses using database for annotation, visualization, and integrated discovery. Cytoscape was utilized to generate a drug-pathway-target-disease network, and molecular docking simulations were performed to evaluate direct interactions between vortioxetine and core target proteins.

Results

A total of 234 unique vortioxetine protein targets were identified. Among 234 vortioxetine targets identified, 48 were also related to glioblastoma. Topological analysis of the PPI network revealed 5 core targets: the serine/threonine kinase AKT1, transcription factor hypoxia-inducible factor (HIF)-1, cell adhesion molecule cadherin-E, NF-κB subunit p105, and prostaglandin-endoperoxide synthase 2. According to GO and KEGG pathway analyses, the anticancer efficacy of vortioxetine may be mediated by effects on glucose metabolism, cell migration, phosphorylation, inflammatory responses, apoptosis, and signaling via Rap1, chemical carcinogenesis-reactive oxygen species, and HIF-1. Molecular docking revealed moderately strong affinities between vortioxetine and 4 core targets.

Conclusions

This study suggests that vortioxetine may inhibit glioblastoma development through direct effects on multiple targets and further emphasizes the value of bioinformatics analyses for drug repositioning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationVortioxetineGlioblastomaProtein Interaction MapsBrain NeoplasmsAntineoplastic AgentsSelective Serotonin Reuptake InhibitorsGene Regulatory NetworksHumansComputational BiologyDrug Repositioning

Stichwörter der Autor:innen

glioblastomamolecular dockingnetwork pharmacologyvortioxetine

Substanzen

VortioxetineAntineoplastic AgentsSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Men…
  • Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PGNP_Lab), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University, Tian…

ORCID-Profile: Chuanjun Zhuo

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhuo, C., Li, C., Zhang, Q., Yang, L., Zhang, Y., Chen, X., Ma, X., Li, R., Wang, L., & Tian, H. (2025). Molecular targets of vortioxetine mediating glioblastoma suppression revealed by gene and protein network analyses and molecular docking simulations. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyaf029

Vancouver

Zhuo C, Li C, Zhang Q, Yang L, Zhang Y, Chen X, et al. Molecular targets of vortioxetine mediating glioblastoma suppression revealed by gene and protein network analyses and molecular docking simulations. International Journal of Neuropsychopharmacology. 2025. doi:10.1093/ijnp/pyaf029

BibTeX
@article{Zhuo2025,
  author = {Zhuo, Chuanjun and Li, Chao and Zhang, Qiuyu and Yang, Lei and Zhang, Ying and Chen, Ximing and Ma, Xiaoyan and Li, Ranli and Wang, Lina and Tian, Hongjun},
  title = {Molecular targets of vortioxetine mediating glioblastoma suppression revealed by gene and protein network analyses and molecular docking simulations},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2025},
  doi = {10.1093/ijnp/pyaf029}
}
Kostenlos starten →